These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28526827)
1. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Zhang R; Yao RR; Li JH; Dong G; Ma M; Zheng QD; Gao DM; Cui JF; Ren ZG; Chen RX Sci Rep; 2017 May; 7(1):2164. PubMed ID: 28526827 [TBL] [Abstract][Full Text] [Related]
2. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition. Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797 [TBL] [Abstract][Full Text] [Related]
3. Activated hepatic stellate cells promote progression of post-heat residual hepatocellular carcinoma from autophagic survival to proliferation. Zhang R; Lin XH; Liu HH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX Int J Hyperthermia; 2019; 36(1):253-263. PubMed ID: 30701994 [TBL] [Abstract][Full Text] [Related]
4. Norepinephrine-stimulated HSCs secrete sFRP1 to promote HCC progression following chronic stress via augmentation of a Wnt16B/β-catenin positive feedback loop. Lin XH; Liu HH; Hsu SJ; Zhang R; Chen J; Chen J; Gao DM; Cui JF; Ren ZG; Chen RX J Exp Clin Cancer Res; 2020 Apr; 39(1):64. PubMed ID: 32293507 [TBL] [Abstract][Full Text] [Related]
5. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway. Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993 [TBL] [Abstract][Full Text] [Related]
6. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation. Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia Enhances Tumor-Stroma Crosstalk that Drives the Progression of Hepatocellular Carcinoma. Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH Dig Dis Sci; 2016 Sep; 61(9):2568-77. PubMed ID: 27074919 [TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells. Qu H; Yang X Cell Biochem Biophys; 2015 Mar; 71(2):931-6. PubMed ID: 25326336 [TBL] [Abstract][Full Text] [Related]
9. The herbal compound Songyou Yin (SYY) inhibits hepatocellular carcinoma growth and improves survival in models of chronic fibrosis via paracrine inhibition of activated hepatic stellate cells. Bu Y; Jia QA; Ren ZG; Xue TC; Zhang QB; Zhang KZ; Zhang QB; You Y; Tian H; Qin LX; Tang ZY Oncotarget; 2015 Nov; 6(37):40068-80. PubMed ID: 26517671 [TBL] [Abstract][Full Text] [Related]
10. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo. Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374 [TBL] [Abstract][Full Text] [Related]
11. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating β-catenin signaling. Zhang N; Wang L; Chai ZT; Zhu ZM; Zhu XD; Ma DN; Zhang QB; Zhao YM; Wang M; Ao JY; Ren ZG; Gao DM; Sun HC; Tang ZY PLoS One; 2014; 9(12):e115949. PubMed ID: 25542041 [TBL] [Abstract][Full Text] [Related]
12. Anticancer Effect of Polyphyllin I in Suppressing Stem Cell-Like Properties of Hepatocellular Carcinoma via the AKT/GSK-3 Liao M; Du H; Wang B; Huang J; Huang D; Tong G Oxid Med Cell Longev; 2022; 2022():4031008. PubMed ID: 36317061 [TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells. Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862 [TBL] [Abstract][Full Text] [Related]
14. Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by down-regulating periostin expression. Sato T; Shizu R; Baba R; Ooka A; Hosaka T; Kanno Y; Yoshinari K Biochem J; 2024 Sep; 481(18):1173-1186. PubMed ID: 39171361 [TBL] [Abstract][Full Text] [Related]
15. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice. Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212 [TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor 15 induces growth and metastasis of human liver cancer stem-like cells via AKT/GSK-3β/β-catenin signaling. Xu Q; Xu HX; Li JP; Wang S; Fu Z; Jia J; Wang L; Zhu ZF; Lu R; Yao Z Oncotarget; 2017 Mar; 8(10):16972-16987. PubMed ID: 28199981 [TBL] [Abstract][Full Text] [Related]
17. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells. Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863 [TBL] [Abstract][Full Text] [Related]
18. A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation. Chen G; Wang Y; Zhao X; Xie XZ; Zhao JG; Deng T; Chen ZY; Chen HB; Tong YF; Yang Z; Ding XW; Guo PY; Yu HT; Wu LJ; Zhang SN; Zhu QD; Li JJ; Shan YF; Yu FX; Yu ZP; Xia JL J Exp Clin Cancer Res; 2021 Jun; 40(1):218. PubMed ID: 34193219 [TBL] [Abstract][Full Text] [Related]
19. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways. Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922 [TBL] [Abstract][Full Text] [Related]